Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Powerful Evaporator for Drug Discovery

Published: Thursday, December 19, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
HT-4X centrifugal evaporator combines ease of use, compactness and operational versatility.

The HT-4X centrifugal evaporator from Genevac provides optimized sample preparation capabilities for scientists working in the drug discovery environment.

Built to the highest specifications, the HT-4X makes demanding applications routine. Corrosive vapours such as trifluoroacetic acid may be removed by the standard system and an inert purge option allows high safety evaporation of flammable solvents.

In addition, the HT-4X can also be used to achieve high speed lyophilization of HPLC fractions and solvents used for reformatting samples.

The HT-4X is a high performance evaporator that combines ease of use, compactness, operational versatility and efficient sample processing.

An innovative built-in dual chamber refrigerated condenser, that combines a powerful cryopump and solvent recovery system, together with extra powerful IR lamps, accelerates the speed of evaporation, even for high boiling point solvents such as DMSO.

In addition, efficient chamber cooling between runs is particularly useful to protect thermally sensitive samples when run immediately after higher boiling point solvents. The system additionally offers an auto-defrosting condenser option and novel functions such as auto shutdown and auto-solvent selection, making it extremely easy to use. Genevac’s patented SampleGuard™ and Dri-Pure® technology is included to protect samples from overheating and bumping.

Operated via an integral full colour screen the Genevac HT-4X offers comprehensive display of real-time data enabling rapid methods development across a wide range of applications.

The easy-to-use system provides facility to store up to 99 evaporation methods making it ideal for multi-user environments.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Installs miVac DNA Concentrator at University of Sheffield
The miVac DNA concentrator will both aid laboratory productivity and ensure samples are prepared safely at the Centre.
Thursday, April 27, 2006
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!